MindWalk Holdings (HYFT) Change in Receivables (2020 - 2026)
MindWalk Holdings (HYFT) reported Change in Receivables of $683100.1 for Q1 2026, up 71.63% year-over-year from $398001.2 in Q1 2025, and up 192.27% quarter-over-quarter from -$740342.7 in Q4 2025.
MindWalk Holdings (HYFT) Change in Receivables (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Change in Receivables data on file, last reported at $683100.1 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $683100.1, up 71.63% year-over-year; the trailing twelve-month figure through Jan 2026 was -$1.1 million (down 96.06% YoY), and the FY2025 annual result was -$213930.4, up 51.74% from the prior year.
- Change in Receivables rose to $683100.1 in Q1 2026 per HYFT's latest filing, from -$740342.7 in the prior quarter.
- Over five years, Change in Receivables peaked at $2.4 million in Q4 2022 and troughed at -$1.1 million in Q4 2024.
- A 5-year average of $422861.6 and a median of $358025.2 in 2024 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 2103.02% in 2024 and fell as far as 9054.0% in 2024.
- A 5-year view of Change in Receivables shows it stood at $2.4 million in 2022, then sank by 99.48% to $12537.4 in 2023, then sank by 9054.0% to -$1.1 million in 2024, then soared by 34.05% to -$740342.7 in 2025, then surged by 192.27% to $683100.1 in 2026.
- Business Quant data shows HYFT's Change in Receivables at $683100.1 in Q1 2026, -$740342.7 in Q4 2025, and -$618617.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -4.08 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 683,100.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 683,100.08 |
| Jan 31, 2026 | 683,100.08 |
| Oct 31, 2025 | -740,342.74 |
| Oct 31, 2025 | -740,342.74 |
| Jul 31, 2025 | -618,617.53 |
| Jul 31, 2025 | -618,617.53 |
| Apr 30, 2025 | -424,448.13 |
| Apr 30, 2025 | -424,448.13 |
| Jan 31, 2025 | 398,001.17 |
| Jan 31, 2025 | 398,001.17 |
| Oct 31, 2024 | -1.12 Mn |
| Oct 31, 2024 | -1.12 Mn |
| Jul 31, 2024 | 930,417.46 |
| Jul 31, 2024 | 930,417.46 |
| Apr 30, 2024 | -767,021.09 |
| Apr 30, 2024 | -767,021.09 |
| Jan 31, 2024 | 358,025.20 |
| Jan 31, 2024 | 358,025.20 |
| Oct 31, 2023 | 12,537.40 |
| Oct 31, 2023 | 12,537.40 |